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Abstract
In our earlier study, noradrenaline (NA) stimulated ATP release from dorsal root ganglion (DRG) neurons as
mediated via b3 adrenoceptors linked to Gs protein involving protein kinase A (PKA) activation, to cause allodynia.
The present study was conducted to understand how ATP is released from DRG neurons. In an outside-out patch-
clamp configuration from acutely dissociated rat DRG neurons, single-channel currents, sensitive to the P2X
receptor inhibitor PPADS, were evoked by approaching the patch-electrode tip close to a neuron, indicating that
ATP is released from DRG neurons, to activate P2X receptor. NA increased the frequency of the single-channel
events, but such NA effect was not found for DRG neurons transfected with the siRNA to silence the cystic fibrosis
transmembrane conductance regulator (CFTR) gene. In the immunocytochemical study using acutely dissociated
rat DRG cells, CFTR was expressed in neurons alone, but not satellite cells, fibroblasts, or Schwann cells. It is
concluded from these results that CFTR mediates NA-induced ATP efflux from DRG neurons as an ATP channel.
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Findings
The dorsal root ganglion (DRG) is a relay point in pain
tracks and a variety of receptors expressed in DRG neu-
rons engage transmission and modulation of pain. ATP
receptors, that include ionotropic P2X receptors and
metabotropic P2Y receptors, serve as a pain mediator in
the DRG [1-9]. A growing body of evidence has pointed
to the role of P2X receptors in acute, inflammatory and
neuropathic pain, P2X3 receptor in spontaneous pain
and heat hyperalgesia, P2X2/3 receptor in acute mechan-
ical allodynia, and P2Y2 receptor in transient receptor
potential vanilloid receptor 1-mediated thermal
hypersensitivity.
Noradrenaline (NA)/adrenoceptor also participates in
the regulation of pain in the DRG. Adrenoceptors are
divided into a1 receptors that include a1a, a1b and a1d
subtypes, a2 receptors that include a2a, a2b, a2c and a2d
subtypes, and b receptors that include b1, b2, b3 and b4
subtypes. Peripheral nerve injury causes sympathetic
nerve sprouting into the DRG [10,11]. Peripheral nerve
axotomy induces hyperexcitation of DRG neurons via a
sympathetic pathway, responsible for neuropathic pain
such as hyperalgesia and allodynia [12]. Sciatic nerve
injury upregulates expression of mRNAs for a1b, a2a,
a2b,a n db2 adrenoceptors in DRG neurons, and NA
potentiates slow type of ATP-evoked currents via a1
adrenoceptors, that are monitored from DRG neurons
[13]. Notably, NA stimulates ATP release from DRG
neurons as mediated via b3 adrenoceptors linked to Gs
protein involving protein kinase A (PKA) activation, to
cause allodynia [14]. DRG neurons form no synapse in
the DRG, and therefore, ATP, to activate the receptors,
is not released from presynaptic terminals. Then, the big
question addressing is where ATP comes from in the
DRG. The present study aimed at answering this
question.
We utilized an outside-out patch-clamp as a biosensor
to monitor ATP mobilizations [14]. Briefly, outside-out
patches were made from acutely dissociated rat DRG
neurons, and single-channel currents, sensitive to pyri-
doxal phosphate-6-azophenyl-2’,4’-disulfonic acid
(PPADS), an inhibitor of P2X receptors, were recorded
by approaching the patch-electrode tip close to a DRG
neuron. If ATP is released from a neuron, then P2X
receptor in an outside-out patch should be activated, to
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mediated neuron-evoked single-channel currents’
(P2XR-NeSCCs)] (Figure 1).
In our earlier study, NA increased the frequency of
P2XR-NeSCCs, i.e., NA stimulated ATP release from
DRG neurons [14]. The NA effect was abolished by
CFTRinh-172, a selective inhibitor of cystic fibrosis
transmembrane conductance regulator (CFTR), while it
was not affected by latrunculin B, an inhibitor of vesicu-
lar transport, or botulinum toxin A, an inhibitor of vesi-
cular exocytosis [14]. This raises the possibility that NA
promotes ATP efflux from DRG neurons through CFTR
but not vesicular ATP release. To obtain direct evidence
for this, we constructed the siRNA to silence the CFTR-
targeted gene (CFTR siRNA). In the single-cell quantita-
tive real-time reverse transcription-polymerase chain
reaction (RT-PCR), expression of the CFTR mRNAs was
significantly suppressed for acutely dissociated rat DRG
neurons transfected with the CFTR siRNA (Figure 2A).
In the single channel recording, NeSCCs, that are
blocked by PPADS (10 μM), i.e., P2XR-NeSCCs, were
obtained by bringing the patch-electrode tip near to
neurons transfected with the negative-control siRNA
( N Cs i R N A )o rt h eC F T Rs i R N A( F i g u r e2 B ) .W h e n
neurons transfected with the NC siRNA were treated
with NA (100 μM), the frequency of P2XR-NeSCCs was
significantly increased as compared with the frequency
before treatment (Figure 2B). In contrast, NA-induced
increase in the frequency of P2XR-NeSCCs was not
obtained for neurons with knocking-down CFTR (Figure
2B). Taken together, these results indicate that NA-sti-
mulated ATP efflux from DRG neurons is CFTR
dependent.
Figure 1 Schematic diagram for P2XR-NeSCC recording.
Outside-out patches were made from acutely dissociated rat DRG
neurons. When the patch-electrode tip is brought within 5 μm close
to a neuron, P2XR-NeSCCs are evoked in response to ATP released
from DRG neurons.
Figure 2 ATP efflux through CFTR. Acutely dissociated rat DRG
neurons were transfected with the NC siRNA or the CFTR siRNA
together with eGFP-expression vector to identify transfected cells.
(A) Single-cell quantitative real-time RT-PCR. The expression level of
the CFTR mRNA was normalized by the expression level of the
GAPDH mRNA. In the graph, each value represents the mean (±
SEM) normalized CFTR mRNA expression (CFTR mRNA/GAPDH
mRNA)(n = 8 independent experiments). P value, unpaired t-test. (B)
P2XR-NeSCCs recording. Outside-out patches were made from DRG
neurons without transfection, and NeSCCs were monitored before
and after treatment with NA (100 μM) in the presence and absence
of PPADS (10 μM) by approaching the patch-electrode tip near to
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out immunocytochemical study using acutely dissociated
rat DRG cells. DRG neurons, fibroblasts, and Schwann
cells were identified with antibodies against microtu-
bule-associated protein 2 (MAP2), fibronectin (FN), and
S-100, respectively (Figure 3). Satellite cells surrounding
neurons were detected with an antibody against glial
fibrillary acidic protein (GFAP)(Figure 3). Immunoreac-
tive signals against an anti-CFTR antibody were homo-
genously found with whole cell bodies of neurons alone
(Figure 3). In contrast, satellite cells, fibroblasts, or
Schwann cells exhibited no signal against an anti-CFTR
antibody (Figure 3). This confirms that CFTR is actually
expressed in DRG neurons.
CFTR is an ABC cassette protein and functions as Cl
-
and ATP channels [15,16]. Intriguingly, CFTR is acti-
vated by PKA phosphorylation of the regulatory domain
[17,18]. In our earlier study, NA-induced increase in the
frequency of P2XR-NeSCCs was inhibited by the selec-
tive b3 adrenoceptor inhibitor SR59230A, knocking-
down b3 adrenoceptors, or the PKA inhibitor H-89 [14],
indicating the implication of b3 adrenoceptors linked to
Gs protein involving PKA activation in the ATP efflux.
neurons transfected with the NC siRNA or the CFTR siRNA. Typical
P2XR-NeSCCs are shown in the upper column. The holding
potential was -70 mV. In the graph, the frequency of P2XR-NeSCCs
was normalized by regarding the frequency before application with
NA (Control) as 1 and each value represents the mean (± SEM)
normalized event frequency (n = 6 independent patches). P values,
Dunnett’s test.
Figure 3 Expression of CFTR in DRG cells. Acutely dissociated rat DRG cells were immunostained with antibodies against MAP2, GFAP,
fibronectin (FN), or S100 together with an anti-CFTR antibody. DIC, differential interference contrast. Bars, 50 μm. Note that satellite cells around
a neuron are detected with an anti-GFAP antibody (arrows) and that immunoreactive signals against an anti-CFTR antibody are found with DRG
neurons only, but not satellite cells, fibroblast, or Schwann cell.
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neurons in a CFTR-dependent manner as mediated via
a b3 adrenoceptor/PKA signaling pathway.
In summary, the results of the present study provide
evidence that CFTR mediates NA-induced ATP efflux
from DRG neurons. This may establish a novel pathway
for activation of ATP receptors under the control of
NA/b3 adrenoceptor.
Materials and methods
Animal care
All procedures have been approved by the Animal Care
and Use Committee at Hyogo College of Medicine and
were in compliance with the National Institutes of
Health Guide for the Care and Use of Laboratory
Animals.
Preparation of DRG cells
The DRGs in the L4 to L6 segment were isolated from
Wistar rats (male, 6 w) and incubated 0.3% (w/v) col-
lagenase at 37°C for 30 min. Then, cells were mechani-
cally dissociated and plated on poly-L-lysine-coated
glass cover slips. Experiments were carried out within
12-24 h after preparation.
Single-channel current recording
Outside-out patches were made from acutely dissociated
DRG neurons. Single-channel currents were monitored
with an Axopatch-200A amplifier (Axon Instruments
Inc., Sunnyvale, CA, USA) in a recording chamber con-
tinuously superfused with an extracellular solution [in
mM; 135 NaCl, 5 KCl, 2.5 CaCl2, 1 MgCl2,5N-2-hydro-
xyethyl piperazine-N’-2-ethansulfonic acid (HEPES), and
10 glucose, pH 7.3] containing 6,7-dinitroquinoxaline-
2,3-dione (DNQX)(20 μM) and DL-2-amino-5-phospho-
nopentanoic acid (DL-AP5)(100 μM )a taf l o wr a t eo f2
ml/min at 21-22°C. The patch electrode-filling solution
was as follows: (in mM) 135 Cs-gluconate, 5 CsCl, 2
MgCl2, 5 ethyleneglycol-bis-(b-aminoethyl ether)-N,N,N’,
N’-tetraacetic acid, 5 HEPES, 5 MgATP, and 1 Na2GTP,
pH 7.2. Currents were analyzed using a pClamp soft-
ware (version 9.2, Axon Instruments Inc.). NA was
bath-applied with an air-pressure injector (PicoPump
PV 820, World Precision Instruments, Stevenage, UK).
Construction and transfection of siRNA
The CFTR siRNA was: 5’-GCUUAAAGGAAGAG-
GAUAUTT-3’ and 5’-AUAUCCUCUUCCUUUAA
GCTT-3’ (B-Bridge International, Inc., Sunnyvale, CA,
USA). The NC siRNA with the scrambled sequence, and
the same GC content and nucleic acid composition was
used as a negative control (B-Bridge International Inc.).
Acutely dissociated neurons were transfected with the NC
siRNA or the CFTR siRNA together with an enhanced
green fluorescence protein (eGFP)-expression vector using
a Nucleofector kit (Amaxa GmbH, Cologne, Germany).
Single-channel recording and single-cell quantitative real-
time RT-PCR were carried out 24 h after transfection.
Single-cell quantitative real-time RT-PCR
An eGFP-positive single DRG neuron was picked up
with a glass capillary containing 18 μll y s i sb u f f e r[ 1 ×
First strand buffer, 0.5 mg/ml bovine serum albumin,
RNase inhibitor, 0.6% NP40, 0.6% Tween 20, anti-sense
primer for CFTR, anti-sense primer for glyceraldehyde-
3-phosphate dehydrogenase (GAPDH), dNTP and 1 mg/
ml yeast tRNA], incubated at 70°C for 1 min to break
the cell membrane. Cell lysate was incubated in the pre-
sence of DNase I at 37°C for 30 min to remove genomic
DNAs and at 70°C for 10 min to inactivate DNase I.
Then, the sample was incubated in a DTT solution con-
taining SuperScript III reverse transcriptase (Invitrogen,
Carlsbad, CA, USA) at 55°C for 40 min followed by at
70°C for 15 min. The gene expression was amplified by
double PCRs. Initially, PCR was carried out in the reac-
tion solution containing 10× PCR buffer, dNTPs, oligo-
nucleotide, dimethyl sulfoxide [final concentration, 5%
(v/v)], and 5 units of Taq polymerase (Fermentas, St.
Leon-Roth, Germany)(final volume, 20 μl) with a PCR
Thermal Cycler Dice (Takara, Otsu, Japan) programmed
as follows: first step, 98°C for 4 min, the ensuring 40
cycles, 98°C for 1 s, 65°C for 15 s, and 72°C for 30 s.
Subsequently, real-time PCR was performed using the
first PCR products with a SYBR Green realtime PCR
Master Mix (Toyobo, Osaka, Japan) and the Applied
Biosystems 7900 real-time PCR detection system (ABI,
Foster City, CA, USA) programmed as follows: first step,
98°C for 4 min; the ensuring 40 cycles, 98°C for 1 s, 65°
C for 15 s, and 72°C for 30 s. The expression level of
rat CFTR mRNA was normalized by that of GAPDH
mRNA. Primers used for RT-PCR were as follows: 5’-
AATATCCTTAGCCCCTCGGA-3’ and 5’-
TGGTGGAAACAATGGCACTA-3’ for CFTR (acces-
sion number M89906) and 5’-CCTTCCGTGTTCC
TACCCCCAAT-3’ and 5’-CCTCTCTCTTGCTCTCAG-
TATCCTTGCT-3’ for GAPDH (accession number
BC059110).
Immunocytochemistry
Acutely dissociated DRG cells were fixed with 4% (w/v)
paraformaldehyde, permeabilized with 0.3% (v/v) Triton
X-100, and blocked with 10% (v/v) goat serum in phos-
phate buffered saline (PBS) at room temperature. Cells
were reacted with a mouse monoclonal antibody for
MAP2 (1:500), GFAP (1:400), S-100 (1:500) or fibronec-
tin (1:500)(Chemicon, Temecula, CA, USA) and a rabbit
polyclonal antibody for CFTR (1:200)(Chemicon) over-
n i g h ta t4 ° Cf o l l o w e db yag o a ta n t i - r a b b i tI g G
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OR, USA) and a goat anti-mouse IgG conjugated with
Alexa 633 (Molecular Probes) for 60 min at room tem-
perature. Fluorescence-labeled cells were visualized with
a confocal scanning laser microscope (Axiovert/
LSM510; Carl Zeiss, Oberkochen, Germany).
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